Study to Evaluate and Compare the PK Profiles of Abaloparatide-SC and Abaloparatide-sMTS in a Cohort of Healthy Men and Healthy Women.
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Healthy Volunteers
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: In each of 2 study periods, subjects received receive either a transdermal patch containing 300 ?g abaloparatide for 5 minutes or an injection of abaloparatide SC 80 ?g.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 40 years and 65 years
- Gender
- Both males and females
Description
This study aims to evaluate and compare the pharmacokinetic (PK) profiles of abaloparatide-SC 80 ?g injected subcutaneously into the periumbilical region of the abdomen, and abaloparatide-sMTS 300 ?g applied to the thigh for 5 minutes in a cohort of healthy men and to make a similar evaluation in a ...
This study aims to evaluate and compare the pharmacokinetic (PK) profiles of abaloparatide-SC 80 ?g injected subcutaneously into the periumbilical region of the abdomen, and abaloparatide-sMTS 300 ?g applied to the thigh for 5 minutes in a cohort of healthy men and to make a similar evaluation in a cohort of healthy women.
Tracking Information
- NCT #
- NCT04663464
- Collaborators
- Medpace, Inc.
- Investigators
- Not Provided
Get Well Soon